Aim of the webinar: 

This webinar will provide an evidence-based overview of exchange transfusion in sickle cell disease, focusing on current guidelines, clinical outcomes, and best practices. It aims to bridge research findings with practical applications in transfusion medicine and therapeutic apheresis.

Level of education required:  

Intermediate (Practical application)

What knowledge is required? 

It is good to have basic knowledge on ABO incompatible hematopoietic stem cell transplantation ad blood groups change after HSCT.

Attendees are encouraged to read the following articles:

 

Target audience

  • Transfusion practitioners and blood bankers
  • Hematopoietic stem cell transplantation physicians
  • Clinical practitioners
  • Scientists, technicians and medical students.

The Speaker

Fatma Burcu Belen Apak

Fatma Burcu Belen Apak

Professor of Pediatric Hematology and Oncology, Baskent University Faculty of Medicine and Pediatric Hematopoietic Stem Cell Transplantation Unit, Ankara, Turkey

Richard R. Gammon will be the moderator at this webinar. 


Are you an ISBT member? Then we have great news! Your CPD points and webinar certificates are automatically saved in My Account – My CPD. Simply log in to the ISBT website using your member credentials to access them. To download your certificate, click on the webinar title in the My CPD area and it will be saved directly to your computer.

Did you know you can also record your own CPD activities here? You’re welcome to use this space to track all your educational activities — even those not directly related to ISBT.

If you enjoyed this webinar, be sure to keep an eye on the ISBT events calendar for upcoming ISBT webinars and Live Journal Clubs. We’d love to welcome you again at future events!

If you’re unable to attend a live session or would like to rewatch a webinar, visit the ISBT webcast library, where you’ll find recordings of all ISBT webinars, Live Journal Clubs, and ISBT congress webcasts. Use the filters to easily find topics that interest you.